Patients with a combination of high NAA10 and low SERPINE1 expression had significantly poorer overall survival compared to the patients with the combination of low NAA10 and high SERPINE1. Together, these results suggested that c-Myc-Naa10p-PAI1 is a critical axis in regulating cell invasiveness and cancer progression of ESCA. The gene discussed is NAA10; the disease is cancer.